XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net loss $ (42,931) $ (52,146)
Adjustments to reconcile net loss to net cash, cash equivalents, and restricted cash used in operating activities    
Depreciation and amortization 5,773 3,328
(Accretion) reduction of lease right-of-use assets (317) 2,179
Loss on extinguishment of liabilities 248  
Share-based compensation expense 6,638 5,373
Change in fair value of warrant liability, net   1,274
Provision for credit losses 887 497
Accrued interest, amortization of debt issuance costs and other 2,462 5,111
Inventory excess and obsolescence 22 166
Impairment loss on intangible assets 238 44
Changes in operating assets and liabilities:    
Accounts receivable (1,811) (4,718)
Other current assets 716 905
Other long-term assets 68 33
Accounts payable and other accrued liabilities 1,637 513
Deferred revenue 248 (755)
Contingent consideration (23,242) (2,494)
Tenant improvement allowances received   18,323
Current and long-term operating lease liabilities 715 (503)
Net cash and cash equivalents and restricted cash used in operating activities (48,649) (22,870)
Cash flows from investing activities    
Purchase of property and equipment (3,230) (22,919)
Patent costs and intangible asset acquisition, net (210) (143)
Net cash and cash equivalents and restricted cash used in investing activities (3,440) (23,062)
Cash flows from financing activities    
Proceeds from the issuance of common stock 55,625 28,126
Proceeds from issuance of common stock under employee stock purchase plan 625 643
Proceeds from exercise of stock options 25 91
Payment of contingent consideration   (8,581)
Proceeds from term loan and notes payable   10,000
Repayment of term loan and notes payable (51) (49)
Payment of debt issuance costs (44) (833)
Equity financing costs (3,685) (80)
Other (445) (188)
Net cash and cash equivalents and restricted cash provided by financing activities 52,050 29,129
Net decrease in cash and cash equivalents and restricted cash (39) (16,803)
Cash, cash equivalents, and restricted cash ‑ beginning of period 26,371 43,174
Cash, cash equivalents, and restricted cash ‑ end of period 26,332 26,371
Supplemental cash flow information:    
Debt issuance costs included in accounts payable and other accrued liabilities   18
Equity financing costs included in accounts payable and other accrued liabilities   43
Issuance of Perceptive Warrants   674
Operating lease right-of-use asset obtained in exchange for lease liabilities 583 797
Finance lease right-of-use assets obtained in exchange for lease liabilities 999 773
Cash paid for interest $ 7,024 3,994
Reclassification of warrant liability to additional paid-in capital   1,335
Purchases of property & equipment included in accounts payable and accrued liabilities   $ 793